Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.

OBJECTIVE--To compare the efficacy and safety of cholestyramine, an anion exchange resin, and pravastatin, a new hydrophilic specific inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, in the treatment of heterozygous familial hypercholesterolaemia. DESIGN--Double blind, double dummy, pla...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Betteridge, D. J., Bhatnager, D., Bing, R. F., Durrington, P. N., Evans, G. R., Flax, H., Jay, R. H., Lewis-Barned, N., Mann, J., Matthews, D. R.
Format: Artigo
Jezik:Inglês
Izdano: 1992
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1882004/
https://ncbi.nlm.nih.gov/pubmed/1611329
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items